SUPPLEMENTAL MATERIAL

DNA Extraction and Genotyping
Genomic DNA was extracted from whole blood using standard methods (QIAamp DNA blood Midi kit, Qiagen). Genotyping for the rs17366568 (functional polymorphism in ADIPOQ gene) and rs266717 SNPs (functional polymorphism in ADIPOQ gene promoter) was performed using TaqMan probes (Applied Biosystems; Assay IDs: C-33187752-10 and C-8288442-10 respectively). The assay was run on an ABI StepOne Plus PCR system according to the manufacturer's protocol.
Harvesting of Human Myocardium and Adipose Tissue Samples
During CABG, myocardial tissue samples were collected from the site of right atrial appendage (RAA) as we have previously described, and transferred into oxygenated (95% O 2 / 5% CO 2 ) ice-cold buffer. Samples of EpAT were harvested from the site of the right atrioventricular groove (inside the pericardial sac, attached to the heart), while thoracic adipose tissue (ThAT) samples were harvested from outside the pericardium (as "control" samples to the EpAT) and transferred in ice-cold phosphate buffer saline. All tissue samples were transferred immediately to the lab and either used for ex-vivo experiments or stored at -80°C for other studies as described below.
Myocardial Superoxide Measurements
Myocardial O 2 .-production was measured in samples of right atrium appendages using lucigenin (5μmol/L)-enhanced chemiluminescence, as we have previously described.
1 Myocardial tissue was homogenised in ice-cold Krebs HEPES Buffer pH 7.35 in the presence of protease inhibitor (Roche Applied Science, Indianapolis, IN) using a pre-cooled Polytron homogeniser. The contribution of NADPH oxidase activity to myocardial O 2 .-production was quantified in the presence of NADPH 100μmol/L. The use of homogenates allows us to overcome issues regarding penetration of NADPH (which is a polar molecule) into the cells or tissue. In certain ex vivo experiments with myocardial tissue, Vas2870 (40 μmol/L, a specific pan NADPH oxidase inhibitor 2 ) was also used to get the Vas2870-inhibitable O 2 .-signal as a more specific index of NADPH oxidase activity. In a pilot experiment comprising 10 RAA samples, we found that VAS2870 inhibitable O 2 .
-(pan-Nox inhibitor) was co-linear to the gp91dstat-inhibitable O 2 .
-(specific for Nox2) with r=0.8875 and P=0.0012. Therefore the use of vas2870 as an NADPH-oxidase inhibitor in the human right atrial appendage provides information mainly on Nox2-derived O 2 .-.
DHE Staining Method
In situ O 2 .-production was determined in right atrial appendage cryosections with the oxidative fluorescent dye dihydroethidium (DHE) as previously described. 3, 4 Briefly, myocardial tissue was washed in ice-cold Krebs HEPES buffer and then cut into thin strips containing all myocardial layers. The tissue was first equilibrated for 20min in Krebs HEPES Buffer pH 7.35 at 37 o C and then incubated for 2 hours in the presence or absence of recombinant full-length adiponectin 0.3 μmol/L (10 μg/ml, BioVendor) +/-CC (10 μmol/L). At the end of the incubation period tissue was collected and snap frozen in OCT. Myocardial cryosections (30μm) were equilibrated in Krebs Hepes buffer with or without Vas2870 (40μmol/L) or peg-SOD (300 U/ml). Then the samples were incubated with DHE (2μmol/L for 5 minutes). Fluorescence images of the myocardium (x63, Zeiss LSM 510 META laser scanning confocal microscope) were obtained from each myocardial tissue quadrant. In each case, segments of myocardial tissue (with and without Vas2870 or peg-SOD) were analyzed in parallel with identical imaging parameters. DHE fluorescence was quantified by using Image-Pro Plus software (Media Cybernetics), while all analyses were performed in a blinded fashion. 
RNA Isolation and
Western Blots in human myocardial samples
To investigate adiponectin-AMPK signaling axis and its effects on NADPH oxidase activity, western immunoblotting was used to examine the direct effects of adiponectin on phospho(Th172)-AMPKa, total AMPKa, phospho(Ser473)-Akt, pan-Akt, phospho(Ser79)-acetyl-CoA carboxylase (ACC) and total ACC (antibodies by Cell Signaling, Danvers, MA), Nox1, Nox2 (antibodies by BD Transduction Laboratories), Nox4, Nox5 (antibodies by Abcam, Cambridge, UK), phospho(Ser359)-p47phox, total p47phox, p67phox (antibodies by Cell Signaling), and total Rac1 (antibody by Merck Millipore, Billerica, MA) protein levels in human myocardium incubated ex-vivo. Selected myocardial tissue samples from Clinical Associations Studies were also used to evaluate the content of 4-hydroxynonenal (4HNE) and malonyldialdehyde (MDA) adducts, the two most common lipid oxidation products (formed when reactive oxygen species react with lipid membranes, antibodies by Abcam) in the presence of high or low myocardial NADPH-stimulated O 2 .-generation. Briefly, myocardial tissue samples were homogenized for 30 seconds using a pre-cooled electric Polytron homogenizer in 300 μl of lysis buffer (Invitrogen, UK) containing a protease and phosphatase inhibitor cocktail (Roche Applied Science). Homogenates were spun at 13,000 rpm for 10 minutes, at 4 ºC. The protein concentration of the supernatants was then measured using the BCATM Protein Assay kit (Pierce, UK). Protein lysates were separated on 4-12% gradient SDS-NuPAGE gel (Invitrogen, UK), and proteins transferred to polyvinylidene difluoride membranes (Amersham, UK Ltd.), followed by blocking with 5% powdered skimmed milk. The membranes were incubated with the respective primary antibodies overnight and immunodetection of the primary antibodies was performed with horseradish-peroxidase-conjugated secondary antibodies (Promega) and enhanced chemifluorescence (Amersham Bioscience UK Ltd.) and quantified in relation to the house-keeping protein, GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA).
Measurement of Myocardial Rac1 Activation and Membrane Translocation Experiments
Rac1 activation was evaluated by a commercially available affinity precipitation assay using the PAK1-PBD conjugated glutathione agarose beads (Millipore, Temecula, USA) 3 . To estimate membrane translocation of Rac1 and p47phox, we performed differential centrifugation for isolation of membrane proteins, and membrane-translocated Rac-1 and p47phox proteins were determined by Western immunoblotting as previously described.
3
Measurement of intracellular NADP/NADPH levels For measurements of intracellular NADP/NADPH levels, a commercially available fluorometric assay was used (Abcam kit, Cambridge, UK). Following the 18 hour treatment, H9C2 cells were washed 3x with PBS and then lysed. Twenty five μl of the lysates were loaded into a black walled 96-well plate for processing. Finally, 75ul of NADPH reaction mixture was added to initiate the reaction according to manufacturer's instructions and after 45 minutes the fluorescence was measured at Ex/Em=540/590nm. The assay kit provides measurements of intracellular NADPH, NADP and total NADPH/NADP separately.
Animal studies
Generating the mouse model: The cardiomyocyte-specific NOX2 overexpressing mouse model (mNOX2-tg) was generated in the laboratory of Ajay Shah. 6 The expression of the human 1.8kb NOX2 cDNA was driven by the mouse myosin light chain-2 (MLC-2v) promoter. Transgenic founders were backcrossed for >10 generations onto a C57BL/6 background.
The decision to overexpress human NOX2 in these mice was based on our findings in Clinical Associations Studies in which NOX2 gene expression was strongly correlated with myocardial O 2 .-in the human right atrium appendages (Online Figure X) , while its activation dependents on p47 phox phosphorylation/membrane translocation and Rac1 activation. On the other hand, unlike Nox2, Nox4 does not require Rac1/p47phox membrane translocation to be activated, and exploring its role in this setting was beyond the scope of the current study.
Pig model: In 10 Dutch Landrace pigs (62±3 kg), anesthesia was induced with Zoletil (5-8mg/kg i.m.) and Thiopenthal (5-15mg/kg i.v.). After intubation, anesthesia was maintained by intravenous infusion of Midazolam (1.0mg/kg/h), Sufentanyl (4mg/kg/h) and Propofol (2.5-10mg/kg/h). An endocardial lead (Capsurefix 5568, Medtronic, Minneapolis, MN) was implanted in the right atrium and connected to a subcutaneous pacemaker (Itrel II, Medtronic, Minneapolis, MN). Healthy pigs (61±2 kg) served as a control group. After one week recovery, the pacemaker was switched on at a rate of 10Hz for 5 weeks. The ventricular rate was controlled by digoxin 10µg/kg for 1 week, followed by 5µg/kg for 4 weeks. Digoxin was discontinued 3 days before the sacrifice experiment in order to reach plasma levels <0.5μg/ml. At sacrifice, animals were anesthetized as described above and the heart was excised via a left lateral incision. Epicardial adipose tissue was collected from the posterior left atrium, close to the AV ring. For comparison, subcutaneous fat was taken from the incision in the thorax.
Power calculations
Sample size calculations were based on previous data from our laboratory. For the clinical studies, we estimated that a total number of 200 subjects would allow us to detect a 0.31 (or 7.5%) difference in log(myocardial NADPH-stimulated O 2 .-) between the extreme tertiles of plasma adiponectin with an α=0.05, a power of 0.9, and an assumed standard deviation of 0.57. For the ex vivo experiments, sample size calculations were performed on the basis of pilot experiments and we estimated that with a minimum of 5 pairs of samples (serial samples from the same myocardial tissue), we would be able to identify a change in log(myocardial NADPH-stimulated O 2 .-) of 0.84 (or 20%) with an α=0.05, a power 0.9, and a standard deviation for a difference in the response of the pairs of 0.44. Power calculations for the animal experiments were based on pilot data on adiponectin expression from epicardial adipose tissue; for the transgenic mice experiments, we estimated that with a minimum of 5 mice per group, we would be able to identify a change in adiponectin gene expression of 0.51 (2fold change) with an α=0.05, a power 0.9, and a standard deviation for a difference in the response of the pairs of 0.22. Similarly, for the pig model of atrial pacing, we estimated that with a minimum of 5 pigs per group, we would be able to identify a change in adiponectin gene expression from epicardial adipose tissue of 0.91 (3fold change) with an α=0.05, a power 0.9, and a standard deviation for a difference in the response of the pairs of 0.39.
Supplemental Tables
Online Table I 
Online Figure II
Effects of recombinant adiponectin on the expression of NADPH oxidase subunits and protein kinase C-a phosphorylation. Human myocardium was incubated ex-vivo for 2h in the presence or absence of recombinant human adiponectin (10μg/mL). Adiponectin did not lead to a significant increase in activity of Akt in this tissue, as assessed by Western blotting for phospho-Ser473 Akt, even though a positive trend was observed (Panel A). There was also no effect of adiponectin on the phosphorylation of protein kinase C-α at Thr497 (PKCα, Panel B), suggesting that its effects on NADPH oxidase were independent of any effects on Akt or PKCα signalling. Moreover, adiponectin did not have any effects on the protein levels of Nox2 and Nox4 isoforms or the protein levels of NADPH oxidase subunits, namely p22 phox , p47 phox and p67 phox (Panel C-D). n=10-12 for the adiponectin group and n=5-7 for the compound C; NS vs control group.
Online Figure III
Changes of intracellular NADP/NADPH levels after incubation with exogenous NADPH. H9C2 cells were incubated with / without NADPH 100μmol/L for 18h, in conditions that mimic the coculture experiments. Then the cells were washed thoroughly and lysed to measure intracellular concentration of NADPH, NADP and total NADP/NADPH using a fluorometric assay. There was a significant increase of both NADPH (by ~25%, A) and NADP (by ~25%, B), with the total NADP/NADPH being increased by ~45% (C) compared to control (**P<0.001 vs control). N=6 independent experiments.
Online Figure IV
Co-culture of rat epicardial adipose tissue and H9C2 cells pre-stimulated with PMA. To examine whether under conditions of increased endogenous oxidative stress cardiomyocytes release a transferable factor able to affect the activation of PPAR-γ/adiponectin signalling in rat epicardial adipose tissue (EpAT), we exposed H9c2 cells to Phorbol-12-Myristate-13-Acetate (PMA, 160 nmol/L) while rat EpAT was conditioned ex vivo (Panel A). After 2h, the rat EpAT was transferred into the H9c2 wells and co-cultured for an additional 16 hours (Panel A). At the end of the incubation period, gene expression of PPAR-γ and ADIPOQ were studied in the rat EpAT. Addition of PMA to intact H9c2 cells grown on coverslips led to a striking increase of NADPH oxidases-derived superoxide (O 
Online Figure IX
Mouse model of cardiomyocyte-specific overexpression of human NOX2. There was no difference in the expression of murine NOX2 in the heart of mNOX2-tg vs the wild type (wt) animals (Panel A). On the contrary, mNOX2-tg mice were over-expressing human NOX2 in their cardiomyocytes, which was not expressed in the wt mice (Panel B). n=9-10 per group; NS: non-significant; ****p<0.0001 vs wt. 
Online Figure XI
Schematic representation of the bi-directional signalling between epicardial adipose tissue and the myocardium. The cross-talk between epicardial adipose tissue (EpAT) and the myocardium involves the release of oxidation products from the heart (4-hydroxynonenal-4HNE) able to trigger peroxisome proliferator activated receptor (PPAR)-γ -induced expression of adiponectin (AdN) in EpAT, which may suppress NADPH oxidases activity in the underlying heart muscle in a paracrine way, via an AMPK (AMP kinase) -dependent activation of Rac1 and phosphorylation of p47phox subunits of NADPH oxidase. AT: Adipose Tissue.
